Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had larger decreases in HbA1c at 28 weeks with mazdutide vs. dulaglutide. More than ...
Patients with poorly controlled type 2 diabetes despite being on dulaglutide had better outcomes if they switched to tirzepatide than if they upped their dulaglutide dose. In this randomized trial, ...
Please provide your email address to receive an email when new articles are posted on . Risk for major adverse CV events was similar for adults receiving tirzepatide vs. dulaglutide. All-cause ...
Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke. (HealthDay News) — Tirzepatide is noninferior to dulaglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results